Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0000875320-24-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-12 | 2024-02-08+ | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $422.49 | -10.7K | 30.3K | -26% | -$4.54M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-08 | F | D | 2,698 | $421.73 | 38,348 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-09 | F | D | 8,048 | $422.74 | 30,300 | D | — | — |